132 related articles for article (PubMed ID: 8759319)
1. X-ray crystallographic structure of recombinant eosinophil-derived neurotoxin at 1.83 A resolution.
Mosimann SC; Newton DL; Youle RJ; James MN
J Mol Biol; 1996 Jul; 260(4):540-52. PubMed ID: 8759319
[TBL] [Abstract][Full Text] [Related]
2. Atomic resolution (0.98 A) structure of eosinophil-derived neurotoxin.
Swaminathan GJ; Holloway DE; Veluraja K; Acharya KR
Biochemistry; 2002 Mar; 41(10):3341-52. PubMed ID: 11876642
[TBL] [Abstract][Full Text] [Related]
3. Toward rational design of ribonuclease inhibitors: high-resolution crystal structure of a ribonuclease A complex with a potent 3',5'-pyrophosphate-linked dinucleotide inhibitor.
Leonidas DD; Shapiro R; Irons LI; Russo N; Acharya KR
Biochemistry; 1999 Aug; 38(32):10287-97. PubMed ID: 10441122
[TBL] [Abstract][Full Text] [Related]
4. Refined crystal structures of native human angiogenin and two active site variants: implications for the unique functional properties of an enzyme involved in neovascularisation during tumour growth.
Leonidas DD; Shapiro R; Allen SC; Subbarao GV; Veluraja K; Acharya KR
J Mol Biol; 1999 Jan; 285(3):1209-33. PubMed ID: 9918722
[TBL] [Abstract][Full Text] [Related]
5. Toxicity of an antitumor ribonuclease to Purkinje neurons.
Newton DL; Walbridge S; Mikulski SM; Ardelt W; Shogen K; Ackerman SJ; Rybak SM; Youle RJ
J Neurosci; 1994 Feb; 14(2):538-44. PubMed ID: 8301353
[TBL] [Abstract][Full Text] [Related]
6. Expression and characterization of a cytotoxic human-frog chimeric ribonuclease: potential for cancer therapy.
Newton DL; Xue Y; Boqué L; Wlodawer A; Kung HF; Rybak SM
Protein Eng; 1997 Apr; 10(4):463-70. PubMed ID: 9194172
[TBL] [Abstract][Full Text] [Related]
7. Structural basis of substrate specificity in porcine RNase 4.
Liang S; Acharya KR
FEBS J; 2016 Mar; 283(5):912-28. PubMed ID: 26748441
[TBL] [Abstract][Full Text] [Related]
8. Refined 1.7 A X-ray crystallographic structure of P-30 protein, an amphibian ribonuclease with anti-tumor activity.
Mosimann SC; Ardelt W; James MN
J Mol Biol; 1994 Mar; 236(4):1141-53. PubMed ID: 8120892
[TBL] [Abstract][Full Text] [Related]
9. Ionic interactions in crystalline bovine pancreatic ribonuclease A.
Fedorov AA; Joseph-McCarthy D; Fedorov E; Sirakova D; Graf I; Almo SC
Biochemistry; 1996 Dec; 35(50):15962-79. PubMed ID: 8973167
[TBL] [Abstract][Full Text] [Related]
10. Role of the N terminus in RNase A homologues: differences in catalytic activity, ribonuclease inhibitor interaction and cytotoxicity.
Boix E; Wu Y; Vasandani VM; Saxena SK; Ardelt W; Ladner J; Youle RJ
J Mol Biol; 1996 Apr; 257(5):992-1007. PubMed ID: 8632481
[TBL] [Abstract][Full Text] [Related]
11. Localization and analysis of nonpolar regions in onconase.
Kolbanovskaya EY; Terwisscha van Scheltinga AC; Mukhortov VG; Ardelt W; Beintema JJ; Karpeisky MY
Cell Mol Life Sci; 2000 Aug; 57(8-9):1306-16. PubMed ID: 11028920
[TBL] [Abstract][Full Text] [Related]
12. High-resolution crystal structures of ribonuclease A complexed with adenylic and uridylic nucleotide inhibitors. Implications for structure-based design of ribonucleolytic inhibitors.
Leonidas DD; Chavali GB; Oikonomakos NG; Chrysina ED; Kosmopoulou MN; Vlassi M; Frankling C; Acharya KR
Protein Sci; 2003 Nov; 12(11):2559-74. PubMed ID: 14573867
[TBL] [Abstract][Full Text] [Related]
13. The ultrahigh resolution crystal structure of ribonuclease A containing an isoaspartyl residue: hydration and sterochemical analysis.
Esposito L; Vitagliano L; Sica F; Sorrentino G; Zagari A; Mazzarella L
J Mol Biol; 2000 Mar; 297(3):713-32. PubMed ID: 10731423
[TBL] [Abstract][Full Text] [Related]
14. Expression and characterization of recombinant human eosinophil-derived neurotoxin and eosinophil-derived neurotoxin-anti-transferrin receptor sFv.
Newton DL; Nicholls PJ; Rybak SM; Youle RJ
J Biol Chem; 1994 Oct; 269(43):26739-45. PubMed ID: 7929408
[TBL] [Abstract][Full Text] [Related]
15. Mapping the ribonucleolytic active site of eosinophil-derived neurotoxin (EDN). High resolution crystal structures of EDN complexes with adenylic nucleotide inhibitors.
Leonidas DD; Boix E; Prill R; Suzuki M; Turton R; Minson K; Swaminathan GJ; Youle RJ; Acharya KR
J Biol Chem; 2001 May; 276(18):15009-17. PubMed ID: 11154698
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of comparative protein modeling by MODELLER.
Sali A; Potterton L; Yuan F; van Vlijmen H; Karplus M
Proteins; 1995 Nov; 23(3):318-26. PubMed ID: 8710825
[TBL] [Abstract][Full Text] [Related]
17. An insertion in loop L7 of human eosinophil-derived neurotoxin is crucial for its antiviral activity.
Sikriwal D; Seth D; Parveen S; Malik A; Broor S; Batra JK
J Cell Biochem; 2012 Oct; 113(10):3104-12. PubMed ID: 22581709
[TBL] [Abstract][Full Text] [Related]
18. Three-dimensional crystal structure of human eosinophil cationic protein (RNase 3) at 1.75 A resolution.
Mallorquí-Fernández G; Pous J; Peracaula R; Aymamí J; Maeda T; Tada H; Yamada H; Seno M; de Llorens R; Gomis-Rüth FX; Coll M
J Mol Biol; 2000 Jul; 300(5):1297-307. PubMed ID: 10903870
[TBL] [Abstract][Full Text] [Related]
19. Crystal structures of ribonuclease A complexes with 5'-diphosphoadenosine 3'-phosphate and 5'-diphosphoadenosine 2'-phosphate at 1.7 A resolution.
Leonidas DD; Shapiro R; Irons LI; Russo N; Acharya KR
Biochemistry; 1997 May; 36(18):5578-88. PubMed ID: 9154942
[TBL] [Abstract][Full Text] [Related]
20. Crystal structure of a polyhistidine-tagged recombinant catalytic subunit of cAMP-dependent protein kinase complexed with the peptide inhibitor PKI(5-24) and adenosine.
Narayana N; Cox S; Shaltiel S; Taylor SS; Xuong N
Biochemistry; 1997 Apr; 36(15):4438-48. PubMed ID: 9109651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]